Boundless Bio, Inc. Common Stock (BOLD) — Financial Flexibility Index
Boundless Bio, Inc. Common Stock (BOLD) has a Financial Flexibility Index of -0.17x as of September 2025. Free cash flow of $-10.18 Million (operating CF $-10.20 Million minus capex $15.00K) represents 0% of total liabilities ($58.55 Million). Also explore BOLD shareholders equity momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Boundless Bio, Inc. Common Stock Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Boundless Bio, Inc. Common Stock across 7 annual periods. Check BOLD financial resilience to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for Boundless Bio, Inc. Common Stock (2016–2024)
Year-by-year free cash flow to debt coverage for Boundless Bio, Inc. Common Stock. For the full company profile including market capitalisation, see market cap of Boundless Bio, Inc. Common Stock.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.05x | $-58.30 Million | $-60.84 Million | $55.77 Million | ▼ -481.3% |
| 2023 | -0.18x | $-46.22 Million | $-46.85 Million | $256.98 Million | ▲ +26.0% |
| 2022 | -0.24x | $-38.53 Million | $-39.60 Million | $158.53 Million | ▼ -74.0% |
| 2021 | -0.14x | $-21.21 Million | $-23.25 Million | $151.91 Million | ▲ +95.7% |
| 2018 | -3.23x | $-96.37 Million | $-107.98 Million | $29.80 Million | ▲ +7.3% |
| 2017 | -3.49x | $-76.96 Million | $-84.51 Million | $22.06 Million | ▼ -144.5% |
| 2016 | -1.43x | $-32.37 Million | $-49.02 Million | $22.69 Million | — |